6CM
BIOR

683 Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

683 Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-496
Closed -$144K – 360
2022
Q1 		$144K Hold
496
– – 0.01% 281
2021
Q4 		$259K Buy
+496
New +$356K 0.01% 271

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

683 Capital Management's BIOR Position: Q2 2022 in Review

683 Capital Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2022, closing a stake of 496 shares — an estimated $144K sold.

683 Capital Management first reported a position in BIOR in Q4 2021 and held it in 2 quarters. The position peaked at $259K in Q4 2021. 46 funds tracked by Wall St. Rank hold BIOR as of Q2 2022.

  • 683 Capital Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • 683 Capital Management sold 496 Biora Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $144K.
  • 683 Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • 683 Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $259K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2022.

Based on 683 Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.